A BMJ investigation looks at the relationship between several FDA commissioners and the companies the agency regulates.
During a Senate Appropriations hearing, FDA commissioner Robert Califf tells lawmakers that the agency is advising against enriched enrollment studies for opioid products from now on.
A BMJ investigation looks at the relationship between several FDA commissioners and the companies the agency regulates.
During a Senate Appropriations hearing, FDA commissioner Robert Califf tells lawmakers that the agency is advising against enriched enrollment studies for opioid products from now on.
DuVal & Associates asks the Supreme Court to hear an appeal of a 1st Circuit Court of Appeals decision upholding the conviction of two former Acclarent executives on misdemeanor charges of distributing misbranded and adulterated medical devices.
FDA publishes a final guidance to clarify the distinctions between medical device remanufacturing and servicing.
